Literature DB >> 15749605

Focal hyperthermia produces progressive tumor necrosis independent of the initial thermal effects.

Mehrdad Nikfarjam1, Caterina Malcontenti-Wilson, Christopher Christophi.   

Abstract

Focal hyperthermia, produced using laser, radio frequency, and microwave, is used to treat liver tumors. The exact mechanisms of tissue destruction using focal hyperthermia are, however, unknown. Clinical and experimental studies suggest a progression of injury after cessation of the initial heat stimulus. This study investigates the mechanisms and time sequence of progressive tissue necrosis induced using focal hyperthermia in a murine model of colorectal liver metastases. Focal hyperthermia produced using a neodymium-yttrium aluminum garnet (Nd-YAG) laser source was applied to the normal liver and colorectal cancer liver metastases in inbred male CBA strain mice. The extent of direct lethal thermal injury was assessed histochemically using vital stain for nicotinamide adenine dinucleotide (NADH) diaphorase immediately after laser application. Tissue injury at subsequent time points was assessed using both NADH diaphorase staining and routine histology to determine the temporal relationship between tissue necrosis and time. Thermal injury occurring immediately after the application of 100 joules of energy was greater in the tumor tissue than in the normal liver (mean [standard error of the mean (SEM)]), measuring 23.5 (3.4) and 16.3 (2.6) mm(3), respectively (P=0.046), despite similar tissue temperature profiles. There was a significant increase in tissue necrosis after initial injury that was greater in the normal liver than in the tumor tissue. In the normal liver, the peak volume of necrosis was 137.4 (9.8) mm(3) and occurred at 3 days, whereas in the tumor tissue the peak was 49.0 (3.5) mm(3) at 4.5 days (P < 0.001). Focal hyperthermia produces tissue necrosis that occurs in two phases. The first phase is caused by the direct lethal thermal injury followed by a second phase involving a progression of necrosis beyond the initial thermal effects. The normal liver and the tumor tissue responded differently to focal hyperthermia. In the tumor tissue, the direct injury is more pronounced, whereas the progression of injury is more rapid and extensive in the normal liver.

Entities:  

Mesh:

Year:  2005        PMID: 15749605     DOI: 10.1016/j.gassur.2004.07.008

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  26 in total

Review 1.  Advances in the treatment of liver tumors.

Authors:  Steven A Curley; James C Cusack; Kenneth K Tanabe; Oliver Stoelzing; Lee M Ellis
Journal:  Curr Probl Surg       Date:  2002-05       Impact factor: 1.909

Review 2.  Current status of hepatic resection.

Authors:  Peter J Allen; William R Jarnagin
Journal:  Adv Surg       Date:  2003

Review 3.  Biologically active products of stimulated liver macrophages (Kupffer cells).

Authors:  K Decker
Journal:  Eur J Biochem       Date:  1990-09-11

4.  Temperature range and selective sensitivity of tumors to hyperthermia: a critical review.

Authors:  J A Dickson; S K Calderwood
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

5.  Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver.

Authors:  W J Wiersinga; M C Jansen; I H Straatsburg; P H Davids; J M Klaase; D J Gouma; T M van Gulik
Journal:  Br J Surg       Date:  2003-03       Impact factor: 6.939

6.  Time-temperature relationship th hyperthermic treatment of malignant and normal tissue in vivo.

Authors:  J Overgaard; H D Suit
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

7.  Changes in microregional perfusion, oxygenation, ATP and lactate distribution in subcutaneous rat tumours upon water-filtered IR-A hyperthermia.

Authors:  D K Kelleher; T Engel; P W Vaupel
Journal:  Int J Hyperthermia       Date:  1995 Mar-Apr       Impact factor: 3.914

8.  Scanning electron microscopy study of the blood supply of human colorectal liver metastases.

Authors:  M Nikfarjam; V Muralidharan; C Malcontenti-Wilson; C Christophi
Journal:  Eur J Surg Oncol       Date:  2003-12       Impact factor: 4.424

9.  Sensitivity to Nd:YAG induced laserthermia is a cell-type-specific feature not directly related to tumorigenic potential or proliferation rate.

Authors:  M Castrén-Persons; T Schröder; E Lehtonen
Journal:  Lasers Surg Med       Date:  1996       Impact factor: 4.025

10.  Microvascular architecture of hepatic metastases in a mouse model.

Authors:  D Kuruppu; C Christophi; P E O'Brien
Journal:  HPB Surg       Date:  1997
View more
  6 in total

1.  Photothermal lesions in soft tissue induced by optical fiber microheaters.

Authors:  Reinher Pimentel-Domínguez; Paola Moreno-Álvarez; Mathieu Hautefeuille; Anahí Chavarría; Juan Hernández-Cordero
Journal:  Biomed Opt Express       Date:  2016-03-03       Impact factor: 3.732

2.  Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases.

Authors:  Theodora Fifis; Caterina Malcontenti-Wilson; Jason Amijoyo; Beatrice Anggono; Vijayaragavan Muralidharan; Mehrdad Nikfarjam; Christopher Christophi
Journal:  HPB (Oxford)       Date:  2011-03-02       Impact factor: 3.647

3.  Radiofrequency ablation of liver tumors: Actual limitations and potential solutions in the future.

Authors:  Beat M Künzli; Paolo Abitabile; Christoph A Maurer
Journal:  World J Hepatol       Date:  2011-01-27

Review 4.  Image-guided percutaneous ablation therapies for local recurrences of thyroid tumors.

Authors:  C M Pacella; E Papini
Journal:  J Endocrinol Invest       Date:  2013-01       Impact factor: 4.256

5.  Magnetic fluid hyperthermia inhibits the growth of breast carcinoma and downregulates vascular endothelial growth factor expression.

Authors:  Guihua Wang; Derong Xu; Qin Chai; Xiaolang Tan; Yu Zhang; Ning Gu; Jintian Tang
Journal:  Oncol Lett       Date:  2014-02-20       Impact factor: 2.967

6.  Ultrasound-Guided Radiofrequency Ablation: A New Attempt to the Treatment of Refractory Hyperparathyroidism Secondary to Chronic Kidney Disease.

Authors:  Dan-Ling Zhang; Sheng Chen; Mei-Zhu Gao; Yu-Cheng Lin; Fu-Yuan Hong; Zhen-Hui You; Xing Chen; Song-Song Wu
Journal:  Kidney Int Rep       Date:  2021-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.